-Frontline.in Interview with Utsa Patnaik, professor emerita of economics, Jawaharlal Nehru University. By T.K. RAJALAKSHMI THE FALLOUT of the decision of the National Democratic Alliance government to demonetise currency of higher denominations has been felt across all sections of people. There are concerns that it will lead to an overall economic slowdown given the acute shortage of currency for industrial and agricultural operations. The impact on agriculture and those dependent on agriculture...

-The Hindu Centre for Politics and Public Policy Prime Minister Narendra Modi's announcement demonetising high denomination notes on November 8, 2016, will do little to address the prime objective of flushing out black money but will adversely affect the economy in the short term, especially the informal sector, which is predominant in India, says M. Govinda Rao, a Member of the Fourteenth Finance Commission and Emeritus Professor, National Institute of Public...

-Deccan Herald System overhaul: Transparency measures with strong accountability mechanisms can usher in change The National Food Security Act (NFSA) passed in 2013 gives statutory backing to the Public Distribution System (PDS). Up to 75% of the rural population and 50% of the urban population is entitled to receive food grain under the Act. Beneficiaries are categorised into priority households, entitled to 5 kg of subsidised grains per person per month, and Antyodaya...

-The Hindu Children from the RTE quota are often left feeling small as equality seems to be lost in monetary disparity Thirty-two-year-old Uma Devi (name changed) is conspicuous in a crowd of parents who have come to pick their children up in swanky cars. She works as a Group D employee at a government hospital, but thanks to the 25 per cent reservation quota mandated by the Right to Education (RTE) Act,...

-The Hindu The proposal to extend the time limit for State-level drug regulatory approvals from four to 10 years could hit the generics market In a scathing letter to the Government of India, the Indian Pharmaceutical Alliance (IPA) took issue with what it considered to be a backdoor extension for data exclusivity norms in the country. It pointed to the recent government proposal to change the four-year time limit for State-level drug...